Show simple item record

dc.contributor.authorTrier, Darin A.
dc.contributor.authorGank, Kimberly D.
dc.contributor.authorKupferwasser, Deborah
dc.contributor.authorYoung, Nannette Y
dc.contributor.authorFrench, William J.
dc.contributor.authorMichelson, Alan D.
dc.contributor.authorKupferwasser, Leon I.
dc.contributor.authorXiong, Yan Q.
dc.contributor.authorBayer, Arnold S.
dc.contributor.authorYeaman, Michael R.
dc.date2022-08-11T08:10:10.000
dc.date.accessioned2022-08-23T16:58:09Z
dc.date.available2022-08-23T16:58:09Z
dc.date.issued2008-12-01
dc.date.submitted2012-04-25
dc.identifier.citationInfect Immun. 2008 Dec;76(12):5706-13. Epub 2008 Sep 29. doi 10.1128/IAI.00935-08. <a href="http://dx.doi.org/10.1128/IAI.00935-08">Link to article on publisher's website</a>
dc.identifier.issn0019-9567 (Linking)
dc.identifier.doi10.1128/IAI.00935-08
dc.identifier.pmid18824536
dc.identifier.urihttp://hdl.handle.net/20.500.14038/43306
dc.description.abstractPlatelets (PLTs) act in antimicrobial host defense by releasing PLT microbicidal proteins (PMPs) or PLT kinocidins (PKs). Receptors mediating staphylocidal efficacy and PMP or PK release versus isogenic PMP-susceptible (ISP479C) and -resistant (ISP479R) Staphylococcus aureus strains were examined in vitro. Isolated PLTs were incubated with ISP479C or ISP479R (PLT/S. aureus ratio range, 1:1 to 10,000:1) in the presence or absence of a panel of PLT inhibitors, including P2X and P2Y receptor antagonists of increasingly narrow specificity, and PLT adhesion receptors (CD41, CD42b, and CD62P). PLT-to-S. aureus exposure ratios of > or = 10:1 yielded significant reductions in the viability of both strains. Results from reversed-phase high-performance liquid chromatography indicated that staphylocidal PLT releasates contained PMPs and PKs. At ratios below 10:1, the PLT antistaphylococcal efficacy relative to the intrinsic S. aureus PMP-susceptible or -resistant phenotype diminished. Apyrase (an agent of ADP degradation), suramin (a general P2 receptor antagonist), pyridoxal 5'-phosphonucleotide derivative (a specific P2X(1) antagonist), and cangrelor (a specific P2Y(12) antagonist) mitigated the PLT staphylocidal response against both strains, correlating with reduced levels of PMP and PK release. Specific inhibition occurred in the presence and absence of homologous plasma. The antagonism of the thromboxane A(2), cyclooxygenase-1/cyclooxygenase-2, or phospholipase C pathway or the hindrance of surface adhesion receptors failed to impede PLT anti-S. aureus responses. These results suggest a multifactorial PLT anti-S. aureus response mechanism involving (i) a PLT-to-S. aureus ratio sufficient for activation; (ii) the ensuing degranulation of PMPs, PKs, ADP, and/or ATP; (iii) the activation of P2X(1)/P2Y(12) receptors on adjacent PLTs; and (iv) the recursive amplification of PMP and PK release from these PLTs.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18824536&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583569/pdf/0935-08.pdf
dc.subjectAnimals
dc.subjectBlood Platelets
dc.subjectChemokines
dc.subjectChromatography, High Pressure Liquid
dc.subjectPlatelet Activation
dc.subjectRabbits
dc.subjectReceptors, Purinergic P2
dc.subjectReceptors, Purinergic P2X
dc.subjectReceptors, Purinergic P2Y12
dc.subjectStaphylococcal Infections
dc.subjectStaphylococcus aureus
dc.subjectHematology
dc.subjectOncology
dc.subjectPediatrics
dc.titlePlatelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release
dc.typeJournal Article
dc.source.journaltitleInfection and immunity
dc.source.volume76
dc.source.issue12
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/peds_hematology/110
dc.identifier.contextkey2796600
html.description.abstract<p>Platelets (PLTs) act in antimicrobial host defense by releasing PLT microbicidal proteins (PMPs) or PLT kinocidins (PKs). Receptors mediating staphylocidal efficacy and PMP or PK release versus isogenic PMP-susceptible (ISP479C) and -resistant (ISP479R) Staphylococcus aureus strains were examined in vitro. Isolated PLTs were incubated with ISP479C or ISP479R (PLT/S. aureus ratio range, 1:1 to 10,000:1) in the presence or absence of a panel of PLT inhibitors, including P2X and P2Y receptor antagonists of increasingly narrow specificity, and PLT adhesion receptors (CD41, CD42b, and CD62P). PLT-to-S. aureus exposure ratios of > or = 10:1 yielded significant reductions in the viability of both strains. Results from reversed-phase high-performance liquid chromatography indicated that staphylocidal PLT releasates contained PMPs and PKs. At ratios below 10:1, the PLT antistaphylococcal efficacy relative to the intrinsic S. aureus PMP-susceptible or -resistant phenotype diminished. Apyrase (an agent of ADP degradation), suramin (a general P2 receptor antagonist), pyridoxal 5'-phosphonucleotide derivative (a specific P2X(1) antagonist), and cangrelor (a specific P2Y(12) antagonist) mitigated the PLT staphylocidal response against both strains, correlating with reduced levels of PMP and PK release. Specific inhibition occurred in the presence and absence of homologous plasma. The antagonism of the thromboxane A(2), cyclooxygenase-1/cyclooxygenase-2, or phospholipase C pathway or the hindrance of surface adhesion receptors failed to impede PLT anti-S. aureus responses. These results suggest a multifactorial PLT anti-S. aureus response mechanism involving (i) a PLT-to-S. aureus ratio sufficient for activation; (ii) the ensuing degranulation of PMPs, PKs, ADP, and/or ATP; (iii) the activation of P2X(1)/P2Y(12) receptors on adjacent PLTs; and (iv) the recursive amplification of PMP and PK release from these PLTs.</p>
dc.identifier.submissionpathpeds_hematology/110
dc.contributor.departmentDepartment of Pediatrics
dc.source.pages5706-13


This item appears in the following Collection(s)

Show simple item record